A Johns Hopkins Children’s Center study of Baltimore City children with asthma shows that two programs designed to improve disease outcomes among those who may be affected the worst fall short of expectations.
The study shows that the Breathmobile, a mobile clinic that brings preventive asthma care and education to low-income, inner-city patients did not improve asthma outcomes, nor did home visits by asthma educators. The combination of the two had minimal and short-lived effects.
The researchers say the findings, published in the Journal of Allergy and Clinical Immunology, underscore the critical need for better ways to reach and engage the most vulnerable pediatric asthma patients and eliminate the barriers that stand between these children and optimal asthma care.
The researchers believe each child treated by the mobile team benefited individually, but the cumulative, population-wide effects remained minimal because only a handful of those eligible for the services actually used them.
Despite free care, multiple locations, and many reminders to schedule a visit, only half the families whose children qualified for mobile clinic care did so, and only 20% of those eligible to receive care showed up for their appointment.
“Parking the Breathmobile in the driveway down the street in and of itself is not enough to make a difference unless we get better at engaging these families and figure out what exactly is stopping them from using these services,” says Kristin Riekert, PhD, senior investigator and an asthma researcher at Hopkins Children’s.
Barriers to care, the investigators say, may include misconceptions about the need for nonurgent asthma care and busy work schedules that preclude daytime appointments.
The study involved 321 low-income children with asthma, ages 2 to 6, followed over 1 year. Patients were divided into four groups: those receiving Breathmobile clinic services, home educational visits, a combination of the two, or neither.
Children in the Breathmobile clinic group underwent a physical exam, including a skin test for common asthma triggers. They were also given prescriptions for asthma controller medications to be taken regularly to prevent airway inflammation and avoid disease flare-ups. Families received the Breathmobile schedule for their neighborhood, as well as several reminders via phone and mail of upcoming Breathmobile visits.
Children in the home-education group received a visit that provided the families with information on basic asthma care and tips on communicating with the child’s primary-care physician. The asthma educators also accompanied patients to an appointment with their pediatricians to ensure better communication.
Children who received both home visits and care at the Breathmobile had 7% more symptom-free days compared with those who got neither. In other words, they had 1.7 more days, per month, on average, free of asthma symptoms. The increase, however, was not sustained beyond 6 months and the difference dissipated within a year.
The study found no notable differences between groups in numbers of emergency room visits, in caregiver quality of life, and in use of rescue fast-acting medication to tame flare-ups—the latter an indicator of poorly controlled disease. The combined-care group experienced 83% fewer hospitalizations, on average, but, once again, these differences disappeared within 1 year.
Source: Johns Hopkins Medicine
